--- title: Abortion Restrictions May Be Affecting Methotrexate Access description: Abortion restrictions may be making some prescription drugs that can be used to induce abortions, like methotrexate, harder to get. canonical: https://time.com/6194179/abortion-restrictions-methotrexate-cancer-arthritis/ author: Jamie Ducharme article:opinion: false article:content_tier: free article:published_time: 2022-07-06T21:48:36.000Z article:modified_time: 2026-02-24T14:28:17.539Z article:section: Health og:title: Abortion Restrictions May Be Making Methotrexate Harder to Access og:description: Some people with arthritis have said they had trouble refilling prescriptions for the drug they need og:url: https://time.com/6194179/abortion-restrictions-methotrexate-cancer-arthritis/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt69b524d82badb34a/698a3376e6e84a55fc2af13b/methotrexate.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 2121 og:image:height: 1193 og:image:alt: Prescription pill bottles og:type: article twitter:card: summary_large_image twitter:title: Abortion Restrictions May Be Making Methotrexate Harder to Access twitter:description: Some people with arthritis have said they had trouble refilling prescriptions for the drug they need twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt69b524d82badb34a/698a3376e6e84a55fc2af13b/methotrexate.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # Abortion Restrictions May Be Making It Harder for Patients to Get a Cancer and Arthritis Drug > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=f600c78f-9280-41ad-a5d4-aa5ee4dfe290&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | Subscribers | Open rate | | --- | --- | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | 540,000 | 45.6% | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | 430,000 | 50.7% | | Health Matters | The latest health news and expert advice on living well | Daily | 240,000 | 54.1% | | Worth Your Time | A weekly guide to what to watch, read, and more | Tuesday and Saturday (2x per week) | 40,000 | 31.7% | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Monday to Saturday (3x per week) | 85,000 | 37.0% | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | 40,000 | 34.2% | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | 25,000 | 28.6% | Source: TIME, August 2026. Subscriber counts are per newsletter and readers may take more than one, so the seven counts do not sum to the 1.1 million+ unique newsletter audience. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Highest open rate | 54.1%, Health Matters | TIME, August 2026 | | Largest list | 540,000, The Brief | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=f600c78f-9280-41ad-a5d4-aa5ee4dfe290&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=f600c78f-9280-41ad-a5d4-aa5ee4dfe290&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (daily health), Worth Your Time (culture, twice weekly), D.C. Brief (Washington politics, three times a week), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.  by [Jamie Ducharme](https://time.com/author/jamie-ducharme/)  ## Jamie Ducharme Ducharme is a contributor to TIME. Jul 6, 2022 9:48 PM UTC  Getty Images  by [Jamie Ducharme](https://time.com/author/jamie-ducharme/)  ## Jamie Ducharme Ducharme is a contributor to TIME. Jul 6, 2022 9:48 PM UTC Soon after she started taking the drug methotrexate in February, Jennifer Crow noticed a significant improvement in her inflammatory arthritis pain. Since then, she’s taken the drug weekly. So her stomach dropped on July 1, when she got an automated call from her pharmacy saying her methotrexate refill for the month hadn’t been approved. Crow, who is 48 and lives in Tennessee, was confused by the disruption, until she saw on social media that [other people](https://twitter.com/%5Ftrashville/status/1543030336266948608) were reporting [similar denials](https://twitter.com/BeccaLizz/status/1542684777693814784). Methotrexate—which in high doses is used as a chemotherapy drug—is sometimes prescribed to induce abortions, complicating its use in states that have restricted abortion access in the aftermath of [_Roe v. Wade_ being overturned](https://time.com/6193895/hope-after-roe-v-wade-overturned/). Crow eventually did get her medication after her doctor re-processed the refill request, but she says temporarily going without it caused her pain and fatigue to flare up—and made her nervous about the future. While neither Crow’s doctor nor her pharmacy explicitly said that methotrexate’s link to abortion affected her prescription, she feels the timing is suspicious. Her home state of Tennessee currently forbids most abortions after about six weeks of pregnancy and is set to implement [a near-total abortion ban next month](https://www.tn.gov/attorneygeneral/news/2022/6/28/pr22-21.html). Crow hopes that, moving forward, pharmacies will have clearer policies about how to handle non-abortion-related methotrexate prescriptions. But if not, “we’re going to be test cases,” she says. “That still worries me.” [Methotrexate](https://medlineplus.gov/druginfo/meds/a682019.html) is an antimetabolite, a class of drug that suppresses certain cellular functions, which is often administered orally or by injection. It’s approved by the U.S. Food and Drug Administration to treat some cancers, but it’s also commonly used for conditions including lupus, arthritis, and psoriasis. Doctors also use it to end ectopic pregnancies, in which a fertilized egg grows outside the uterus, resulting in an unviable pregnancy that carries the risk of life-threatening complications for the pregnant person. Methotrexate ends the pregnancy by preventing cells from dividing. While methotrexate is not one of the drugs typically used in an elective [medication abortion](https://time.com/6190341/how-abortion-pills-work/)—those drugs are [mifepristone and misoprostol](https://time.com/6181162/abortion-pill-access-roe-v-wade/)—it can be [used for that purpose](https://pubmed.ncbi.nlm.nih.gov/10342080/). Pregnant people are advised not to take methotrexate because it may cause serious harm to the fetus. Some states, like [Texas](https://capitol.texas.gov/tlodocs/872/billtext/html/SB00004F.HTM), have laws that specifically list methotrexate as an abortion-inducing drug, placing restrictions on its use. Texas’ law does note, however, that such drugs are prescribed for non-abortion-related reasons that are exempt from those regulations. Other states make similar distinctions. In Kentucky, a “trigger” law banned nearly all abortions in the state after _Roe v. Wade_ was overturned, though that [policy is now tied up in court](https://www.kentucky.com/news/politics-government/article263206058.html). But on July 1, the Kentucky Board of Pharmacy emailed pharmacists and pharmacy interns in the state to remind them that, under Kentucky state law, “if a pharmacist receives a prescription and it doesn’t say, ‘for the induction of abortion,’ they can assume that it’s not for abortion,” explains executive director Christopher Harlow. This means pharmacists may fill prescriptions for drugs like methotrexate normally, if there’s no indication that it’s meant for abortion. Harlow says the board has not received any reports of patients being denied prescriptions. But other organizations say they have. “We have heard of a handful of cases of patients being completely denied \[prescriptions\] simply because they’re of childbearing age,” says Steven Newmark, director of policy at the Global Healthy Living Foundation, a nonprofit that supports people with chronic illnesses. Other patients have been told they “need to go back to their doctor, or the pharmacist has to check with the doctor, or the doctor is being wary and more reluctant” to prescribe drugs like methotrexate, Newmark says. Michael Murphy, advisor for state government affairs at the American Pharmacists Association, says pharmacists may be reluctant to fill methotrexate prescriptions if they practice in states where providers can be held legally or financially liable for performing abortion services. Laws vary quite a bit from state to state, and many leave enough gray area that it’s not always obvious when or how someone could be liable. It’s also not clear how many patients have been denied methotrexate, though [a ](https://twitter.com/sadgorlzai/status/1544072032106823689)[number](https://twitter.com/sadgorlzai/status/1544072032106823689) of [people](https://twitter.com/acrowandthedead/status/1541602157492948994) have [shared their experiences](https://twitter.com/Vinminen/status/1540437651198824448) on social media. Several health groups—including the [Lupus Foundation of America](https://twitter.com/LupusOrg/status/1543329679507161088), [Arthritis Foundation](https://twitter.com/ArthritisFdn/status/1542864354290327559), and [American College of Rheumatology](https://twitter.com/ACRheum/status/1542513794160611334)—recently posted statements about reported access issues and told patients to contact them if they ran into problems. Murphy says reports of patients being denied methotrexate are anecdotal, so it’s hard to get a handle on how common they are. But, he says, “any reports of patients not being able to receive their medications and maintain that continuity of their care is very concerning for us as pharmacists.” Newmark says he hopes states will pledge to preserve access to these medications, hopefully before it becomes a widespread issue. “If things don’t get remedied quickly,” he says, “it’s going to require more action.” ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6194179/abortion-restrictions-methotrexate-cancer-arthritis/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6194179/abortion-restrictions-methotrexate-cancer-arthritis/"},"headline":"Abortion Restrictions May Be Making It Harder for Patients to Get a Cancer and Arthritis Drug","datePublished":"2022-07-06T21:48:36.000Z","dateModified":"2026-02-24T14:28:17.539Z","description":"Some people with arthritis have said they had trouble refilling prescriptions for the drug they need","url":"https://time.com/6194179/abortion-restrictions-methotrexate-cancer-arthritis/","keywords":["abortion","healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt69b524d82badb34a/698a3376e6e84a55fc2af13b/methotrexate.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Jamie Ducharme","jobTitle":"Ducharme is a contributor to TIME.","url":"https://time.com/author/jamie-ducharme/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt69b524d82badb34a/698a3376e6e84a55fc2af13b/methotrexate.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Prescription pill bottles","caption":"Prescription pill bottles","creditText":"Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/abortion/","name":"abortion"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6194179/abortion-restrictions-methotrexate-cancer-arthritis/","name":"Abortion Restrictions May Be Making It Harder for Patients to Get a Cancer and Arthritis Drug"}}]}] ```